Your browser doesn't support javascript.
loading
Effect of extracorporeal photopheresis on survival in acute graft versus host disease.
Kaya, Ahmet; Erkurt, Mehmet Ali; Kuku, Irfan; Kaya, Emin; Berber, Ilhami; Biçim, Soykan; Hidayet, Emine; Cirik, Salih; Arslan, Süleyman; Yagin, Fatma Hilal; Sarici, Ahmet.
Affiliation
  • Kaya A; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Erkurt MA; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Kuku I; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Kaya E; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Berber I; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Biçim S; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Hidayet E; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Cirik S; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Arslan S; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
  • Yagin FH; Faculty of Medicine, Department of Biostatistics and Medical Informatics, Inonu University, Malatya, Turkey.
  • Sarici A; Turgut Ozal Medical Center, Department of Hematology, Inonu University, Malatya, Turkey.
J Clin Apher ; 38(5): 602-610, 2023 Oct.
Article de En | MEDLINE | ID: mdl-37421294
ABSTRACT

BACKGROUND:

Extracorporeal photopheresis (ECP) is the main non-pharmacological approach accompanying systemic medical treatments in steroid-resistant acute or chronic graft versus host disease. The study aimed to examine the effect of ECP on survival in acute graft versus host disease (aGVHD).

METHODS:

A total of 35 patients who were followed up in the adult hematology clinic of Inönü University Turgut Özal Medical Center for aGVHD were included in the study. Stem cell transplantation and ECP application parameters that may affect the survival of the patients were examined.

RESULTS:

In aGVHD using ECP, the degree of involvement affects survival. Involvements with a clinical and laboratory score (Glucksberg system) of 2 and above significantly reduced survival. The duration of ECP use is associated with survival. Especially, 45 days and longer use increases survival (hazard ratio, P-value <.05). The duration of steroid use was found to be effective in survival in aGVHD (P < .001). ECP administration day (P = .003), duration of steroid use (P < .001), duration of ECP use (P = .001), and grade of aGVHD (P < .001) affect survival.

CONCLUSION:

ECP use is effective in survival in patients with aGVHD score ≥2. In patients with aGVHD, especially the use of 45 days and longer has a positive effect on survival. The duration of steroid use is associated with survival in aGVHD.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Clin Apher Année: 2023 Type de document: Article Pays d'affiliation: Turquie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Clin Apher Année: 2023 Type de document: Article Pays d'affiliation: Turquie